These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 835120)

  • 1. [Role of drug information].
    Lunde PK
    Tidsskr Nor Laegeforen; 1977 Jan; 97(3):150-1. PubMed ID: 835120
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of drug reports for the P&T Committee.
    Longe RL; Cross GW; Riley MW
    Hosp Formul; 1978 Mar; 13(3):228-9. PubMed ID: 10306915
    [No Abstract]   [Full Text] [Related]  

  • 3. [Institution for pharmacotherapy].
    Naess K; Nordbo K
    Tidsskr Nor Laegeforen; 1977 Feb; 97(4):195-7. PubMed ID: 841550
    [No Abstract]   [Full Text] [Related]  

  • 4. Developing Drug Reports for the Pharmacy and Therapeutics Committee.
    Longe RL; Riley MW
    Am J Hosp Pharm; 1976 Jul; 33(7):651-2. PubMed ID: 941920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic approach to writing P&T drug reports.
    Longe RL
    Hosp Formul; 1978 Feb; 13(2):128-9. PubMed ID: 10306341
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse drug effects: evaluation of four secondary reference sources.
    Lyon RA
    Hosp Formul; 1985 Mar; 20(3):315-7, 320-1. PubMed ID: 10270307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The goals and functions of a P & T committee.
    Sudds TW; Williams RR
    Hosp Formul; 1985 Nov; 20(11):1163-5, 1171, 1174. PubMed ID: 10274572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reaction reporting in Canadian hospitals.
    Naylor MJ
    Can J Hosp Pharm; 1978; 31(5):184. PubMed ID: 10239058
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacotherapeutic information explosion and medical practice].
    Dahlström H
    Lakartidningen; 1972 Sep; 69(40):4512-4. PubMed ID: 5072438
    [No Abstract]   [Full Text] [Related]  

  • 10. [Letter: The role of the National Board of Health and Welfare in drug information].
    Liljestrand A; Rosén A
    Lakartidningen; 1976; 73(20):1881-2. PubMed ID: 1271917
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug committees, choice of drugs and drug information].
    Lundh B
    Lakartidningen; 1988 Nov; 85(44):3641-3. PubMed ID: 3199994
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse reaction reporting program.
    Knobloch CP
    J Am Vet Med Assoc; 1980 Jan; 176(1):29. PubMed ID: 6892526
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug information services in Nepal: the changing perspectives.
    Chhetri AK; Palaian S; Mishra P
    Kathmandu Univ Med J (KUMJ); 2008; 6(1):117-21. PubMed ID: 18604128
    [No Abstract]   [Full Text] [Related]  

  • 14. [Future drug committees--institutions for cooperation and information].
    Odeberg H; Lenhoff K
    Lakartidningen; 1989 Jan; 86(1-2):34. PubMed ID: 2911227
    [No Abstract]   [Full Text] [Related]  

  • 15. Using the register of adverse drug reactions.
    Drug Ther Bull; 1977 Sep; 15(18):69. PubMed ID: 891365
    [No Abstract]   [Full Text] [Related]  

  • 16. The Canadian drug adverse reaction reporting program.
    Napke E
    Drug Inf J; 1975; 9(2-3):224-32. PubMed ID: 10236976
    [No Abstract]   [Full Text] [Related]  

  • 17. Twenty years' experience with drug information centers.
    Amerson AB; Wallingford DM
    Am J Hosp Pharm; 1983 Jul; 40(7):1172-8. PubMed ID: 6881155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection and prevention of drug-induced lesions. 20 years' experiences in the Drug Committee of the German Medical Society].
    Homann G
    Internist (Berl); 1973 Jan; 14(1):19-24. PubMed ID: 4576792
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beginning of work of the service for the monitoring of side-effects of drug therapy in the SAP Vojvodina].
    Stanulovíc M
    Med Pregl; 1977; 30(3-4):221-2. PubMed ID: 875931
    [No Abstract]   [Full Text] [Related]  

  • 20. [Work of the committee on drug side effects].
    Naes K
    Tidsskr Nor Laegeforen; 1975 Aug; 95(22):1237-8. PubMed ID: 1162664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.